Pfizer Joins Foundation Medicine to Develop Cancer CDx

Foundation Medicine said today it will partner with Pfizer to develop and commercialize companion diagnostics (CDx) for the pharma giant’s oncology portfolio, through a collaboration whose value was not disclosed.Foundation Medicine said the companion diagnostics would be launched as updates to the company’s FoundationOne CDx, an FDA-approved comprehensive genomic profiling (CGP) assay for all solid tumors that incorporates multiple tests.Under the collaboration, Pfizer will gain acc